Martire G, Lovisa F, Carraro E, Rizzato D, Cesaro S, Mura RM, Tondo A, Bertolin C, Boaretto F, Salviati L, Biffi A, Pillon M, Mussolin L. <i>TP53</i> DNA binding domain mutational status and rituximabbased treatment are independent prognostic factors for pediatric Burkitt lymphoma patients stratification. haematol [Internet]. 2024Sep.1 [cited 2024Dec.12];109(9):3031-6. Available from: https://haematologica.org/article/view/haematol.2023.284868